Skip to main content
×
Home
    • Aa
    • Aa

Intradermal hepatitis B immunization with yeast-derived vaccine: serological response by sex and age

  • C. A. Morris (a1), P. R. Oliver (a1), F. Reynolds (a1) and J. B. Selkon (a2)
Abstract
SUMMARY

The efficacy and acceptability of yeast-derived recombinant hepatitis B vaccine given by the intradermal route was investigated in 221 health care volunteers. Two hundred and sixteen received a full course of three doses of vaccine. Only one subject was withdrawn because of a significant adverse reaction (psoriasis). The vaccine stimulated an antibody response in 81%. The response to the vaccine was better in women than in men (87% compared with 71%, p = 0·007) and in women below the age of 40 years compared with older women (94% compared with 76%, p = 0·01). For men the response showed a sequential decline with age for each decade (90% responders from age 29 or less, 72% aged 30—39 and 65% aged 40 or more, p = 0·04). Retrospective enquiry showed that over 90% had found the intradermal route acceptable and 59% would prefer vaccine by the intradermal route in preference to intramuscular notwithstanding local reactions. Although the seroconversion rate was of a high order in younger women the antibody titres were not high with only 9 of 215 recipients developing titres >1000 mIU/ml, a level which could be expected to ensure prolonged immunity. A fourth intradermal dose of vaccine given to 60 volunteers who had shown a low response (<38 mIU/ml) or no serological response to a three-dose course stimulated a good booster effect (to 150—600 mIU/ml) in only 5 (8%).

Copyright
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

3.JL. Dienstag Low dose intradermal hepatitis B vaccine. JAMA 1986; 256: 351.

9.G Fadda , A Maida , C Masia , G Obino , G Romano , E. Spano Efficacy of hepatitis B immunisation with reduced intradermal doses. Eur J Epidemiol 1987; 3: 176–80.

10.NA Halsey , EJ Reppert , HS Margolis , DP Francis , HA. Fields Intradermal hepatitis B vaccination in an abbreviated schedule. Vaccine 1986: 4: 228–32.

12.HC Whittle , WM Lamb , RW. Ryder Trials of intradermal hepatitis B vaccine in Gambian children. Ann Trop Paediatr 1987: 7: 69.

13.EA Ayoola , MA Atoba , AO. Johnson Intradermal vaccination against hepatitis B virus infection in an endemic area (Nigeria), two year results. Arch Virol 1986: 91: 291–6.

15.MM Horowitz , WM Ershler , WP McKinney , RJ. Battiola Duration of immunity after hepatitis B vaccination: efficacy of low-dose booster vaccine. Ann Intern Med 1988: 108: 185–9.

16.S Nagafuchi , S Kashiwagi , T Lnoue , S. Imayama Development of skin reactions to hepatitis B vaccine in man. Microbiol Immunol 1984: 28: 275–9.

20.J Alexander , WH. Stimson Sex hormones and the course of parasitic infection. Parasitology Today, 1988; 4: Part 7; 189–93.

21.Morbidity and Mortality Weekly Report. Trends: safety of hepatitis B vaccine. J Amer Med Assoc 1983, 249: 1812.

23.WJ. Saxonhouse Hepatitis vaccine. J Am Dent Assoc 1985: 110: 670.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×